Phillip Bacilla, MD
Sports Medicine · Alexandria, LANPI 1598732133
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Arthrex at 42.4% of the total. Reporting peaked in 2023 at $1,806 and has fallen 63.3% since, to $663 in 2025.
Across 74 payments — averaging $81.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Stryker$2K
- ALON Medical Technology$1K
- Pacira Pharmaceuticals Incorporated$84
- Trice Medical, Inc.$42
- Pacira Therapeutics, Inc.$32
- plus $30 from 1 others
What the payments were for
- Travel & lodging$2,47241%
- Food & beverage$2,60343%
- Education$94216%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 33 | $2,551 |
| Stryker | 30 | $1,899 |
| ALON Medical Technology | 5 | $1,379 |
| Pacira Pharmaceuticals Incorporated | 1 | $84 |
| Trice Medical, Inc. | 1 | $42 |
| Pacira Therapeutics, Inc. | 2 | $32 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,049
How this compares
$6,017 in reported general payments places this provider in the 60th percentile of 82 sports medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $5,569 |
| Diclofenac Sodium | 59 | $733 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 65 | $541 |
| Meloxicam | 123 | $403 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 33 | $248 |
| Methocarbamol | 20 | $206 |
| Prednisone | 64 | $202 |
| Celecoxib | 12 | $187 |
| Gabapentin | 15 | $118 |
| Tramadol Hcl | 55 | $116 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 24 | $75 |
| Doxycycline Hyclate | 20 | $72 |
| Doxycycline Monohydrate | 13 | $70 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Alexandria
- Michael LeddyAlexandria$44K
- Jamie RisterAlexandria$26K
- Felix SavoieNew Orleans$1.4M
- Misty SuriNew Orleans$1.2M
- Michael ObrienNew Orleans$391K
- Brett CascioLake Charles$82K
- Brian GodshawNew Orleans$69K
- Andrew GottschalkJefferson$45K
- Steven JonesHammond$38K
- Mario Lobao GoncalvesShreveport$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.